Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 4—April 2022
Synopsis

Increasing Antimicrobial Resistance in World Health Organization Eastern Mediterranean Region, 2017–2019

Maha TalaatComments to Author , Bassem Zayed, Sara Tolba, Enjy Abdou, Mohamed Gomaa, Dana Itani, Yvan Hutin, and Rana Hajjeh
Author affiliation: World Health Organization Eastern Mediterranean Region, Cairo, Egypt

Main Article

Figure 1

Proportion of patients with bloodstream infections caused by antimicrobial resistant pathogens in 14 World Health Organization Eastern Mediterranean Region countries. Data from the Global Antimicrobial Resistance Surveillance System (https://www.who.int/glass) for 2019. Each dot represents the percentage of patients with resistant organisms in a country. Horizontal lines within boxes indicate medians, box tops and bottoms indicate interquartile ranges (middle 50% of data), and error bars (upper and lower whiskers) represent scores outside the middle 50%. CRAsp, carbapenem-resistant Acinetobacter spp., CREC, carbapenem-resistant Escherichia coli; CRKP, carbapenem-resistant K. pneumoniae; E. coli, Escherichia coli; K. pneumoniae, Klebsiella pneumoniae; MRSA, methicillin-resistant Staphylococcus aureus; 3CG, third-generation cephalosporins.

Figure 1. Proportion of patients with bloodstream infections caused by antimicrobial resistant pathogens in 14 World Health Organization Eastern Mediterranean Region countries. Data from the Global Antimicrobial Resistance Surveillance System (https://www.who.int/glass) for 2019. Each dot represents the percentage of patients with resistant organisms in a country. Horizontal lines within boxes indicate medians, box tops and bottoms indicate interquartile ranges (middle 50% of data), and error bars (upper and lower whiskers) represent scores outside the middle 50%. CRAsp, carbapenem-resistant Acinetobacter spp., CREC, carbapenem-resistant Escherichia coli; CRKP, carbapenem-resistant K. pneumoniae; E. coli, Escherichia coli; K. pneumoniae, Klebsiella pneumoniae; MRSA, methicillin-resistant Staphylococcus aureus; 3CG, third-generation cephalosporins.

Main Article

Page created: January 10, 2022
Page updated: March 19, 2022
Page reviewed: March 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external